Back to search

United States· US:55910-339_c1d634e7-eed9-407c-94d5-61c3d52b557c

Saline Laxative Cherry

A medicinal product containing sodium phosphate, dibasic; sodium phosphate, monobasic, unspecified form, registered in United States by Dolgencorp Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedSaline Laxative CherryATC—REGISTER NO.US:55910-339_c1d634e7…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM
Manufacturer
Dolgencorp Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    5591033924
    1 BOTTLE in 1 CARTON (55910-339-24) / 45 mL in 1 BOTTLE
  • ndc11
    55910-339-24

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sodium phosphate, dibasic; sodium phosphate, monobasic, unspecified form in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sodium phosphate, dibasic; sodium phosphate, monobasic, unspecified form products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Italy · Phospho Lax, Sodio Fosfato Alfasigma
  • Netherlands · Colex Klysma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9fc9dcf7-930a-4118-aa77-b6f7d82d143c
GET /v1/drugs/9fc9dcf7-930a-4118-aa77-b6f7d82d143c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "2.7; 7.2",
  "substance": "SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM",
  "productndc": "55910-339",
  "dosage_form": "LIQUID",
  "dea_schedule": null,
  "strength_unit": "g/45mL; g/45mL",
  "application_number": "part334",
  "marketing_category": "OTC MONOGRAPH NOT FINAL"
}

See everything about sodium phosphate, dibasic; sodium phosphate, monobasic, unspecified form.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.